VYVGART Hytrulo University image of couple with laptop

VYVGART Hytrulo (You)niversity official logo - A patient educational university programI'd like to learn more about the VYVGART Hytrulo (You)niversity program for CIDP, including the live events.

Discover the potential of VYVGART Hytrulo

Living with chronic inflammatory demyelinating polyneuropathy (CIDP) can be challenging. Whether you're an adult living with CIDP, a caregiver, or a friend of the CIDP community, join us to learn more about VYVGART Hytrulo.

Hear from CIDP experts

Listen and interact with CIDP experts as they take you through an in-depth look at VYVGART Hytrulo.

Firsthand experience

Meet a CIDP patient who will provide their personalized perspective about their experience on VYVGART Hytrulo.

Get questions answered

Have the opportunity to ask questions about VYVGART Hytrulo live at the event.

VYVGART Hytrulo (You)niversity heading for Virtual section - a person at a desk using a computer online

VIRTUAL

VYVGART Hytrulo (You)niversity heading for In-person events - people attending a university educational program

IN-PERSON

Have questions or prefer to register via phone?

Call us at 1-833-LEARN-VH between 8AM and 9PM EST, Monday - Saturday.

Stay up to date on VYVGART Hytrulo

Register to receive VYVGART Hytrulo updates, CIDP community events, and CIDP resources.

Register for a VYVGART
(You)niversity Program

Register for a VYVGART Hytrulo
(You)niversity Event

 

*Indicates a required field

*By checking this box, you are at least 18 years old and with your consent, argenx may contact you for marketing purposes, such as to provide you with information, offers and promotions regarding argenx therapeutic areas, products, and programs, to conduct market research or surveys, and to use your Information to develop future products, services and programs.

You understand that you may withdraw your authorization provided above by emailing or following the unsubscribe instructions on the communication. Unless you withdraw this authorization, it will remain effective for two years. Copies of this authorization may be obtained by emailing [email protected].

SUBMIT

Thank you for registering! We look forward to you attending the VYVGART Hytrulo (You)niversity event.

Keep an eye on your inbox so you don't miss out on important updates about the event.

There was a problem

Please check your information and try again

Return to form

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

IMPORTANT SAFETY INFORMATION

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions).
    VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions.
    VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see accompanying full Prescribing and Patient Information for VYVGART HYTRULO.